General Information of the Compound
Compound ID |
CP0560932
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[(2R,3R)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(tetrazol-1-yl)acetamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C25H30ClN7O6S
|
||||||||||||||||||
Molecular Weight |
592.078
|
||||||||||||||||||
Canonical SMILES |
C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(Cl)cc2)Oc2ccc(NC(=O)Cn3cnnn3)cc2C1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C25H30ClN7O6S/c1-16-11-33(17(2)14-34)25(36)21-10-19(28-24(35)13-32-15-27-29-30-32)6-9-22(21)39-23(16)12-31(3)40(37,38)20-7-4-18(26)5-8-20/h4-10,15-17,23,34H,11-14H2,1-3H3,(H,28,35)/t16-,17-,23+/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
URQKONJVLVDPPP-QZMQVMSPSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound